Patent ID: 9320727
Filing Date: 2016-04-26
CPC Classification: A61K,A61P

Claim Text:
1. A method for treating a disease involving at least hypertension or diabetes mellitus as a risk factor of cardiovascular events, which comprises administering (i) an SGLT2 inhibitor which is (1S)-1,5-anhydro-1-[3-(4-ethoxybenzyl)-6-methoxy-4-methylphenyl]-1-thio-D-glucitol, a pharmaceutically acceptable salt thereof, a hydrate of the compound or salt, and (ii) an antihypertensive compound selected from the group consisting of lisinopril and valsartan, or a pharmaceutically acceptable salt thereof, or a hydrate of the compound or salt, either simultaneously or separately, to a patient in need thereof.